Early post-operative use of Botulinum toxin type A in prevention of scar after mammoplasty and abdominoplasty

Australas J Dermatol. 2022 Feb;63(1):111-113. doi: 10.1111/ajd.13734. Epub 2021 Oct 26.

Authors

Sadrollah Motamed¹, Rohollah Bakhshi¹, Keshvad Hedayatyanfard^{2

3}, Nazgol-Sadat Haddadi⁴, Azadeh Khalili², Gholamreza Bayat², Bahareh Tavakoli-Far², Abdolreza Roeintan¹

Affiliations

¹ Department of Plastic and Reconstructive Surgery, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
² Department of Physiology and Pharmacology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
³ Cardiovascular Research Center, Alborz University of Medical Sciences, Karaj, Iran.
⁴ Departments of Dermatology, University of Massachusetts School of Medicine, Worchester, Massachusetts, USA.

PMID: 34699057
DOI: 10.1111/ajd.13734

No abstract available

Publication types

Letter

MeSH terms

Abdominoplasty / adverse effects*
Botulinum Toxins, Type A / therapeutic use*
Cicatrix / etiology
Cicatrix / prevention & control*
Female
Humans
Mammaplasty / adverse effects*
Postoperative Care / methods
Treatment Outcome
Wound Healing*

Substances

Botulinum Toxins, Type A